News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BG Medicine Cuts Estimated IPO Price Range to $8-$10/Shr



12/6/2007 6:24:59 AM

Dec 6 (Reuters) - Molecular diagnostics company BG Medicine Inc cut the estimated price range of its initial public offering of 4.5 million shares to $8 to $10 a share, from $14 to $16 per share, according to a regulatory filing.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES